Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Octreotide Market Report 2021

  • QYR673105
  • 105 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Octreotide

Revenue, means the sales value of Octreotide

This report studies sales (consumption) of Octreotide in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Novartis

Sun Pharmaceutical

Teva

UNITED BIOTECH

Taj Group

Chengdu Tiantaishan pharmaceutical

Sinopharm A-Think Pharmaceuticals

Sihuan Pharmaceutical Holdings Group

Shanghai Soho-Yiming Pharmaceuticals

Yibin Pharmaceutical

Teva

UNITED BIOTECH

Taj Group

CSC Pharmaceuticals International

ADITYA PHARMA

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Octreotide in these regions, from 2011 to 2021 (forecast), like

Germany

France

UK

Italy

Spain

Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Octreotide Injection

Octreotide Powder

Octreotide Microsphere

Split by applications, this report focuses on sales, market share and growth rate of Octreotide in each application, can be divided into

Tumors

Bleeding esophageal varices

Radiolabelling

Table of Contents

1 Octreotide Overview

1.1 Product Overview and Scope of Octreotide

1.2 Classification of Octreotide

1.2.1 Octreotide Injection

1.2.2 Octreotide Powder

1.2.3 Octreotide Microsphere

1.3 Applications of Octreotide

1.3.1 Tumors

1.3.2 Bleeding esophageal varices

1.3.3 Radiolabelling

1.4 Octreotide Market by Regions

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Italy Status and Prospect (2011-2021)

1.4.5 Spain Status and Prospect (2011-2021)

1.4.6 Russia Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Octreotide (2011-2021)

1.5.1 Europe Octreotide Sales, Revenue and Price (2011-2021)

1.5.2 Europe Octreotide Sales and Growth Rate (2011-2021)

1.5.3 Europe Octreotide Revenue and Growth Rate (2011-2021)

2 Europe Octreotide by Manufacturers, Type and Application

2.1 Europe Octreotide Market Competition by Manufacturers

2.1.1 Europe Octreotide Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Octreotide Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Octreotide (Volume and Value) by Type

2.2.1 Europe Octreotide Sales and Market Share by Type (2011-2021)

2.2.2 Europe Octreotide Revenue and Market Share by Type (2011-2021)

2.3 Europe Octreotide (Volume and Value) by Regions

2.3.1 Europe Octreotide Sales and Market Share by Regions (2011-2021)

2.3.2 Europe Octreotide Revenue and Market Share by Regions (2011-2021)

2.4 Europe Octreotide (Volume) by Application

3 Germany Octreotide (Volume, Value and Sales Price)

3.1 Germany Octreotide Sales and Value (2011-2021)

3.1.1 Germany Octreotide Sales and Growth Rate (2011-2021)

3.1.2 Germany Octreotide Revenue and Growth Rate (2011-2021)

3.1.3 Germany Octreotide Sales Price Trend (2011-2021)

3.2 Germany Octreotide Sales and Market Share by Manufacturers

3.3 Germany Octreotide Sales and Market Share by Type

3.4 Germany Octreotide Sales and Market Share by Applications

4 UK Octreotide (Volume, Value and Sales Price)

4.1 UK Octreotide Sales and Value (2011-2021)

4.1.1 UK Octreotide Sales and Growth Rate (2011-2021)

4.1.2 UK Octreotide Revenue and Growth Rate (2011-2021)

4.1.3 UK Octreotide Sales Price Trend (2011-2021)

4.2 UK Octreotide Sales and Market Share by Manufacturers

4.3 UK Octreotide Sales and Market Share by Type

4.4 UK Octreotide Sales and Market Share by Applications

5 France Octreotide (Volume, Value and Sales Price)

5.1 France Octreotide Sales and Value (2011-2021)

5.1.1 France Octreotide Sales and Growth Rate (2011-2021)

5.1.2 France Octreotide Revenue and Growth Rate (2011-2021)

5.1.3 France Octreotide Sales Price Trend (2011-2021)

5.2 France Octreotide Sales and Market Share by Manufacturers

5.3 France Octreotide Sales and Market Share by Type

5.4 France Octreotide Sales and Market Share by Applications

6 Italy Octreotide (Volume, Value and Sales Price)

6.1 Italy Octreotide Sales and Value (2011-2021)

6.1.1 Italy Octreotide Sales and Growth Rate (2011-2021)

6.1.2 Italy Octreotide Revenue and Growth Rate (2011-2021)

6.1.3 Italy Octreotide Sales Price Trend (2011-2021)

6.2 Italy Octreotide Sales and Market Share by Manufacturers

6.3 Italy Octreotide Sales and Market Share by Type

6.4 Italy Octreotide Sales and Market Share by Applications

7 Russia Octreotide (Volume, Value and Sales Price)

7.1 Russia Octreotide Sales and Value (2011-2021)

7.1.1 Russia Octreotide Sales and Growth Rate (2011-2021)

7.1.2 Russia Octreotide Revenue and Growth Rate (2011-2021)

7.1.3 Russia Octreotide Sales Price Trend (2011-2021)

7.2 Russia Octreotide Sales and Market Share by Manufacturers

7.3 Russia Octreotide Sales and Market Share by Type

7.4 Russia Octreotide Sales and Market Share by Applications

8 Spain Octreotide (Volume, Value and Sales Price)

8.1 Spain Octreotide Sales and Value (2011-2021)

8.1.1 Spain Octreotide Sales and Growth Rate (2011-2021)

8.1.2 Spain Octreotide Revenue and Growth Rate (2011-2021)

8.1.3 Spain Octreotide Sales Price Trend (2011-2021)

8.2 Spain Octreotide Sales and Market Share by Manufacturers

8.3 Spain Octreotide Sales and Market Share by Type

8.4 Spain Octreotide Sales and Market Share by Applications

9 Europe Octreotide Manufacturers Analysis

9.1 Novartis

9.1.1 Company Basic Information,Manufacturing Base and Competitors

9.1.2 Octreotide Product Type and Technology

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Octreotide Sales, Revenue, Price of Novartis (2015 and 2016)

9.2 Sun Pharmaceutical

9.2.1 Company Basic Information,Manufacturing Base and Competitors

9.2.2 Octreotide Product Type and Technology

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Octreotide Sales, Revenue, Price of Sun Pharmaceutical (2015 and 2016)

9.3 Teva

9.3.1 Company Basic Information,Manufacturing Base and Competitors

9.3.2 Octreotide Product Type and Technology

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Octreotide Sales, Revenue, Price of Teva (2015 and 2016)

9.4 UNITED BIOTECH

9.4.1 Company Basic Information,Manufacturing Base and Competitors

9.4.2 Octreotide Product Type and Technology

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Octreotide Sales, Revenue, Price of UNITED BIOTECH (2015 and 2016)

9.5 Taj Group

9.5.1 Company Basic Information,Manufacturing Base and Competitors

9.5.2 Octreotide Product Type and Technology

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Octreotide Sales, Revenue, Price of Taj Group (2015 and 2016)

9.6 Chengdu Tiantaishan pharmaceutical

9.6.1 Company Basic Information,Manufacturing Base and Competitors

9.6.2 Octreotide Product Type and Technology

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Octreotide Sales, Revenue, Price of Chengdu Tiantaishan pharmaceutical (2015 and 2016)

9.7 Sinopharm A-Think Pharmaceuticals

9.7.1 Company Basic Information,Manufacturing Base and Competitors

9.7.2 Octreotide Product Type and Technology

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Octreotide Sales, Revenue, Price of Sinopharm A-Think Pharmaceuticals (2015 and 2016)

9.8 Sihuan Pharmaceutical Holdings Group

9.8.1 Company Basic Information,Manufacturing Base and Competitors

9.8.2 Octreotide Product Type and Technology

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Octreotide Sales, Revenue, Price of Sihuan Pharmaceutical Holdings Group (2015 and 2016)

9.9 Shanghai Soho-Yiming Pharmaceuticals

9.9.1 Company Basic Information,Manufacturing Base and Competitors

9.9.2 Octreotide Product Type and Technology

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Octreotide Sales, Revenue, Price of Shanghai Soho-Yiming Pharmaceuticals (2015 and 2016)

9.10 Yibin Pharmaceutical

9.10.1 Company Basic Information,Manufacturing Base and Competitors

9.10.2 Octreotide Product Type and Technology

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Octreotide Sales, Revenue, Price of Yibin Pharmaceutical (2015 and 2016)

9.11 Teva

9.11.1 Company Basic Information,Manufacturing Base and Competitors

9.11.2 Octreotide Product Type and Technology

9.11.2.1 Type I

9.11.2.2 Type II

9.11.3 Octreotide Sales, Revenue, Price of Teva (2015 and 2016)

9.12 UNITED BIOTECH

9.12.1 Company Basic Information,Manufacturing Base and Competitors

9.12.2 Octreotide Product Type and Technology

9.12.2.1 Type I

9.12.2.2 Type II

9.12.3 Octreotide Sales, Revenue, Price of UNITED BIOTECH (2015 and 2016)

9.13 Taj Group

9.13.1 Company Basic Information,Manufacturing Base and Competitors

9.13.2 Octreotide Product Type and Technology

9.13.2.1 Type I

9.13.2.2 Type II

9.13.3 Octreotide Sales, Revenue, Price of Taj Group (2015 and 2016)

9.14 CSC Pharmaceuticals International

9.14.1 Company Basic Information,Manufacturing Base and Competitors

9.14.2 Octreotide Product Type and Technology

9.14.2.1 Type I

9.14.2.2 Type II

9.14.3 Octreotide Sales, Revenue, Price of CSC Pharmaceuticals International (2015 and 2016)

9.15 ADITYA PHARMA

9.15.1 Company Basic Information,Manufacturing Base and Competitors

9.15.2 Octreotide Product Type and Technology

9.15.2.1 Type I

9.15.2.2 Type II

9.15.3 Octreotide Sales, Revenue, Price of ADITYA PHARMA (2015 and 2016)

10 Octreotide Technology and Development Trend

10.1 Octreotide Technology Analysis

10.2 Octreotide Technology Development Trend

11 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Octreotide

Table Classification of Octreotide

Figure Europe Sales Market Share of Octreotide by Types in 2015

Figure Octreotide Injection Picture

Figure Octreotide Powder Picture

Figure Octreotide Microsphere Picture

Table Applications of Octreotide

Figure Europe Sales Market Share of Octreotide by Applications in 2015

Figure Tumors Examples

Figure Bleeding esophageal varices Examples

Figure Radiolabelling Examples

Figure Germany Octreotide Revenue and Growth Rate (2011-2021)

Figure France Octreotide Revenue and Growth Rate (2011-2021)

Figure UK Octreotide Revenue and Growth Rate (2011-2021)

Figure Italy Octreotide Revenue and Growth Rate (2011-2021)

Figure Spain Octreotide Revenue and Growth Rate (2011-2021)

Figure Russia Octreotide Revenue and Growth Rate (2011-2021)

Table Europe Octreotide Sales, Revenue and Price (2011-2021)

Figure Europe Octreotide Sales and Growth Rate (2011-2021)

Figure Europe Octreotide Revenue and Growth Rate (2011-2021)

Table Europe Octreotide Sales of Key Manufacturers (2015 and 2016)

Table Europe Octreotide Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Octreotide Sales Share by Manufacturers

Figure 2016 Octreotide Sales Share by Manufacturers

Table Europe Octreotide Revenue by Manufacturers (2015 and 2016)

Table Europe Octreotide Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Octreotide Revenue Share by Manufacturers

Table 2016 Europe Octreotide Revenue Share by Manufacturers

Table Europe Octreotide Sales and Market Share by Type (2011-2021)

Table Europe Octreotide Sales Share by Type (2011-2021)

Figure Sales Market Share of Octreotide by Type (2011-2021)

Figure Europe Octreotide Sales Growth Rate by Type (2011-2021)

Table Europe Octreotide Revenue and Market Share by Type (2011-2021)

Table Europe Octreotide Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Octreotide by Type (2011-2021)

Figure Europe Octreotide Revenue Growth Rate by Type (2011-2021)

Table Europe Octreotide Sales and Market Share by Regions (2011-2021)

Table Europe Octreotide Sales Share by Regions (2011-2021)

Figure Sales Market Share of Octreotide by Regions (2011-2021)

Figure Europe Octreotide Sales Growth Rate by Regions (2011-2021)

Table Europe Octreotide Revenue and Market Share by Regions (2011-2021)

Table Europe Octreotide Revenue Share by Regions (2011-2021)

Figure Revenue Market Share of Octreotide by Regions (2011-2021)

Figure Europe Octreotide Revenue Growth Rate by Regions (2011-2021)

Table Europe Octreotide Sales and Market Share by Application (2011-2021)

Table Europe Octreotide Sales Share by Application (2011-2021)

Figure Sales Market Share of Octreotide by Application (2011-2021)

Figure Europe Octreotide Sales Growth Rate by Application (2011-2021)

Figure Germany Octreotide Sales and Growth Rate (2011-2021)

Figure Germany Octreotide Revenue and Growth Rate (2011-2021)

Figure Germany Octreotide Sales Price Trend (2011-2021)

Table Germany Octreotide Sales by Manufacturers (2015 and 2016)

Table Germany Octreotide Market Share by Manufacturers (2015 and 2016)

Table Germany Octreotide Sales by Type (2015 and 2016)

Table Germany Octreotide Market Share by Type (2015 and 2016)

Table Germany Octreotide Sales by Applications (2015 and 2016)

Table Germany Octreotide Market Share by Applications (2015 and 2016)

Figure UK Octreotide Sales and Growth Rate (2011-2021)

Figure UK Octreotide Revenue and Growth Rate (2011-2021)

Figure UK Octreotide Sales Price Trend (2011-2021)

Table UK Octreotide Sales by Manufacturers (2015 and 2016)

Table UK Octreotide Market Share by Manufacturers (2015 and 2016)

Table UK Octreotide Sales by Type (2015 and 2016)

Table UK Octreotide Market Share by Type (2015 and 2016)

Table UK Octreotide Sales by Applications (2015 and 2016)

Table UK Octreotide Market Share by Applications (2015 and 2016)

Figure France Octreotide Sales and Growth Rate (2011-2021)

Figure France Octreotide Revenue and Growth Rate (2011-2021)

Figure France Octreotide Sales Price Trend (2011-2021)

Table France Octreotide Sales by Manufacturers (2015 and 2016)

Table France Octreotide Market Share by Manufacturers (2015 and 2016)

Table France Octreotide Sales by Type (2015 and 2016)

Table France Octreotide Market Share by Type (2015 and 2016)

Table France Octreotide Sales by Applications (2015 and 2016)

Table France Octreotide Market Share by Applications (2015 and 2016)

Figure Italy Octreotide Sales and Growth Rate (2011-2021)

Figure Italy Octreotide Revenue and Growth Rate (2011-2021)

Figure Italy Octreotide Sales Price Trend (2011-2021)

Table Italy Octreotide Sales by Manufacturers (2015 and 2016)

Table Italy Octreotide Market Share by Manufacturers (2015 and 2016)

Table Italy Octreotide Sales by Type (2015 and 2016)

Table Italy Octreotide Market Share by Type (2015 and 2016)

Table Italy Octreotide Sales by Applications (2015 and 2016)

Table Italy Octreotide Market Share by Applications (2015 and 2016)

Figure Russia Octreotide Sales and Growth Rate (2011-2021)

Figure Russia Octreotide Revenue and Growth Rate (2011-2021)

Figure Russia Octreotide Sales Price Trend (2011-2021)

Table Russia Octreotide Sales by Manufacturers (2015 and 2016)

Table Russia Octreotide Market Share by Manufacturers (2015 and 2016)

Table Russia Octreotide Sales by Type (2015 and 2016)

Table Russia Octreotide Market Share by Type (2015 and 2016)

Table Russia Octreotide Sales by Applications (2015 and 2016)

Table Russia Octreotide Market Share by Applications (2015 and 2016)

Figure Spain Octreotide Sales and Growth Rate (2011-2021)

Figure Spain Octreotide Revenue and Growth Rate (2011-2021)

Figure Spain Octreotide Sales Price Trend (2011-2021)

Table Spain Octreotide Sales by Manufacturers (2015 and 2016)

Table Spain Octreotide Market Share by Manufacturers (2015 and 2016)

Table Spain Octreotide Sales by Type (2015 and 2016)

Table Spain Octreotide Market Share by Type (2015 and 2016)

Table Spain Octreotide Sales by Applications (2015 and 2016)

Table Spain Octreotide Market Share by Applications (2015 and 2016)

Table Novartis Basic Information List

Table Octreotide Sales, Revenue, Price of Novartis (2015 and 2016)

Table Sun Pharmaceutical Basic Information List

Table Octreotide Sales, Revenue, Price of Sun Pharmaceutical (2015 and 2016)

Table Teva Basic Information List

Table Octreotide Sales, Revenue, Price of Teva (2015 and 2016)

Table UNITED BIOTECH Basic Information List

Table Octreotide Sales, Revenue, Price of UNITED BIOTECH (2015 and 2016)

Table Taj Group Basic Information List

Table Octreotide Sales, Revenue, Price of Taj Group (2015 and 2016)

Table Chengdu Tiantaishan pharmaceutical Basic Information List

Table Octreotide Sales, Revenue, Price of Chengdu Tiantaishan pharmaceutical (2015 and 2016)

Table Sinopharm A-Think Pharmaceuticals Basic Information List

Table Octreotide Sales, Revenue, Price of Sinopharm A-Think Pharmaceuticals (2015 and 2016)

Table Sihuan Pharmaceutical Holdings Group Basic Information List

Table Octreotide Sales, Revenue, Price of Sihuan Pharmaceutical Holdings Group (2015 and 2016)

Table Shanghai Soho-Yiming Pharmaceuticals Basic Information List

Table Octreotide Sales, Revenue, Price of Shanghai Soho-Yiming Pharmaceuticals (2015 and 2016)

Table Yibin Pharmaceutical Basic Information List

Table Octreotide Sales, Revenue, Price of Yibin Pharmaceutical (2015 and 2016)

...

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390